In the literature: September 2023
-
Published:2023-12
Issue:6
Volume:8
Page:102032
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Lamarca A.ORCID,
Moreno V.,
Gambardella V.ORCID,
Cervantes A.ORCID
Subject
Cancer Research,Oncology
Reference15 articles.
1. Molecular targeted therapies: ready for ‘prime time’ in biliary tract cancer;Lamarca;J Hepatol,2020
2. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Vogel;Ann Oncol,2023
3. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study;Pant;Lancet Oncol,2023
4. Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma;Mazzaferro;Br J Cancer,2019
5. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study;Abou-Alfa;Lancet Oncol,2020